BETHLEHEM, Pa.--(BUSINESS WIRE)--June 26, 2006--B. Braun Medical Inc., a global leader in innovative healthcare products and services, today announced the launch of CeFOXItin 1g and 2g for injection in the DUPLEX® Drug Delivery System. Approved for use with CeFOXItin by the U.S. Food and Drug Administration (FDA) on March 10, 2006, DUPLEX is now the only ready-to-use IV drug delivery system available for CeFOXItin therapy in the United States.
